By Francis Ying and Julie Appleby and Stephanie Stapleton May 21, 2018
Francis Ying and Julie Appleby, Kaiser Health News and Stephanie Stapleton
Guess who’s again grabbing headlines? Pharmacy profit managers — these firms that function middlemen within the prescription drug pipeline. President Donald Trump’s plan to reduce the cost of medicines targets so-called PBMs as major culprits behind the nation’s out-of-control drug costs. At KHN, we have been speaking about them last week and have written about their function within the market for a while.
But customers usually don’t discover or perceive PBMs and the way they issue into figuring out prices on the pharmacy counter. This KHN video, introduced out from our vault, particulars the emergence of those multimillion-dollar firms and the affect they’ve on treatment prices and sufferers’ entry to therapies.
For extra data on drug pricing points, try this chart and these movies:
Tracking Who Makes Money On A Brand-Name Drug
Sounds Like A Good Idea? Regulating Drug Prices
KHN additionally affords different movies analyzing scorching subjects akin to selling insurance across state lines, high-risk insurance pools, Medicare’s observation care status and the way the well being regulation could possibly be disassembled by way of the congressional budget reconciliation process.
KHN’s protection of prescription drug improvement, prices and pricing is supported partly by the Laura and John Arnold Foundation and its protection in California is funded partly by Blue Shield of California Foundation.
Kaiser Health News (KHN) is a nationwide well being coverage information service. It is an editorially unbiased program of the Henry J. Kaiser Family Foundation which isn’t affiliated with Kaiser Permanente.
Copy HTML
We encourage organizations to republish our content material, freed from cost. Here’s what we ask:
You should credit score us as the unique writer, with a hyperlink to our khn.org website. If potential, please embrace the unique writer(s) and “Kaiser Health News” within the byline. Please protect the hyperlinks within the story.
It’s vital to notice, not the whole lot on khn.org is accessible for republishing. If a narrative is labeled “All Rights Reserved,” we can not grant permission to republish that merchandise.
Have questions? Let us know at KHNHelp@kff.org”>KHNHelp@kff.org